Biotechnology

Filter

Current filters:

None

Popular Filters

2201 to 2225 of 2323 results

Germany’s IQWIG negative on InterMune’s Esbriet

18-12-2011

US biotech firm InterMune (Nasdaq: ITMN) says that Germany’s private Institute for Quality and Efficiency…

BiotechnologyEsbrietEuropeInterMuneRare diseasesRegulationRespiratory and Pulmonary

European Medicines Agency’s 2012 work program and budget

18-12-2011

The European Medicines Agency’s Management Board, at its meeting on 15 December 15, adopted the…

BiotechnologyEuropeFinancialGenericsPharmaceuticalRegulationResearch

Where to now for UK Life Sciences?

16-12-2011

The 2012 UK Life Science Industry Leaders Survey* highlights a concern that the UK is losing its position…

BiotechnologyEuropeFinancialPharmaceuticalPricingRegulationResearch

BioSante female libido drug flops in Ph III studies

16-12-2011

its two pivotal Phase III LibiGel (testosterone gel) efficacy trials, joining the list of failures in…

BioSante PharmaceuticalsBiotechnologyLibiGelResearchWomen's Health

Intellect Neurosciences appeals European patent decision

15-12-2011

US neuro drug discovery firm Intellect Neurosciences (OTCBB: ILNS) says that it has filed an appeal regarding…

bapineuzumabBiotechnologyElanIntellect NeuroscienceLegalNeurologicalPatentsPfizerPharmaceutical

Investment in medicines highest in PHARMAC history

15-12-2011

A surge in the medicines budget over the past three years, combined with New Zealand’s health regulatory…

Asia-PacificBiotechnologyFinancialPharmaceuticalPricingRegulation

Onyx joins with MMRF to advance MM targeted therapies

15-12-2011

US biotech firm Onyx Pharmaceuticals (Nasdaq: ONXX) has joined forces with the Multiple Myeloma Research…

BiotechnologyNorth AmericaOncologyOnyx PharmaceuticalsPharmaceuticalResearch

BioLineRx inks deal with Compugen

14-12-2011

Israeli biopharma company BioLineRx (TASE: BLRX) has entered into a collaboration with fellow Israel-based…

BioLineRxBiotechnologyCardio-vascularCompugenInflammatory diseasesLicensingOncologyPharmaceuticalResearch

More news briefs from ASH meeting

14-12-2011

In ongoing news from the American Society of Hematology (ASH) meeting taking place in San Diego, Swiss…

AmgenBiotechnologydaratumumabExjadeGenmabMerck & CoNovartisNplateOncologyPharmaceuticalResearchZolinza

Ablynx earns milestone from Merck Serono

13-12-2011

Belgium’s Ablynx (Euronext Brussels: ABLX) says it will earn a 1 million-euro ($1.3 million) from…

AblynxBiotechnologyFinancialImmunologicalsMerck KGaAMerck SeronoPharmaceuticalResearch

Actelion pulls out of Trophos option

13-12-2011

Switzerland-based Actelion (SIX: ATLN), Europe’s biggest biotech company, says that it has decided…

ActelionBiotechnologyLicensingMergers & AcquisitionsolesoximePharmaceuticalRare diseasesTrophos

Highlights of ASH meeting

13-12-2011

Among presentations at this year’s Annual Meeting of the American Society of Hematology (ASH), held…

AEterna ZentarisAriad PharmaceuticalsBiotechnologyblinatumomabMicrometOncologyperifosinePharmaceuticalPharmacyclicsponatinibResearch

Gene therapy achieves early success in hemophilia

12-12-2011

Symptoms improved significantly in adults with the hereditary bleeding disorder hemophilia B following…

BiotechnologyRare diseasesResearch

2 billion-euro EU grant for Israeli project

12-12-2011

The Joint Management Authority of the European Neighborhood and Partnership Instrument (ENPI CBC MED…

BiotechnologyEuropeFinancialResearchRest of the World

Abbott in further deal with Reata

12-12-2011

US health care major Abbott Laboratories (NYSE: ABT) has entered into a second mega-million dollar licensing…

Abbott LaboratoriesAnti-Arthritics/RheumaticsbardoxoloneBiotechnologyLicensingNeurologicalPharmaceuticalReata Pharmaceuticals

TaiGen gets global nemonoxacin rights

11-12-2011

Taiwan’s TaiGen Biotechnology has reached a deal with Ireland-headquartered Warner Chilcott (Nasdaq:…

Antibiotics and Infectious diseasesBiotechnologyLicensingnemonoxacinPharmaceuticalTaiGen BiotecnologyWarner Chilcott

EUnetHTA position paper developed

11-12-2011

The European Network for Health Technology Assessment (EUnetHTA) Joint Action Conference in Gdansk, Poland,…

BiotechnologyEuropeRegulation

MAbs largest class of biotherapeutics

08-12-2011

Monoclonal antibodies (MAbs) were the fastest growing segment in the global pharmaceutical market in…

BiotechnologyMarkets & Marketing

FDA plans biosimilars user fee talks

08-12-2011

The US Food and Drug Administration has published a Federal Register notice announcing a December 16…

BiotechnologyFinancialGenericsNorth AmericaRegulation

Dendreon cashes in Victrelis royalty

08-12-2011

US pharma company Dendreon (Nasdaq: DNDN) says that it has agreed to sell for $125 million in cash its…

Anti-viralsBiotechnologyDendreonFinancialLicensingMerck & CoOncologyPharmaceuticalProvengeVictrelis

FDA eases REMS requirements for Amgen’s Nplate and GSK’s Promacta

07-12-2011

The US Food and Drug Administration says that an agency initiated review of the current information has…

AmgenBiotechnologyGlaxoSmithKlineNorth AmericaNplatePharmaceuticalPromactaRare diseasesRegulation

Novartis in licensing deal with Cellectis; pays milestone to GenVec

07-12-2011

Paris, France-based Cellectis genome engineering specialist (Alternext: ALCLS) has signed a license agreement…

BiotechnologyCellectisGenVecLicensingNeurologicalNovartisPharmaceutical

2201 to 2225 of 2323 results

Back to top